To explore the effect of the phlegm-resolving, lung-regulating and asthma-relieving decoction as an adjuvant therapy for acute exacerbation of chronic obstructive pulmonary disease(AECOPD) with phlegm-heat accumulation in the lung syndrome and its influence on complement C3, C4 and blood gas indicators.
A total of 120 patients diagnosed with AECOPD with phlegm-heat accumulation in the lung syndrome at Linquan ccounty people's hospital from January 2022 to January 2025 were selected as the research subjects and divided into the observation group and the control group, with 60 cases in each group. Both groups were given conventional western medicine treatment, and the observation group additionally received phlegm-resolving, lung-regulating and asthma-relieving decoction as an adjuvant treatment. The clinical efficacy, C3, C4, blood gas indicators, pulmonary function indicators, and traditional Chinese medicine(TCM) syndrome scores before and after treatment were compared between the two groups.
The total effective rate of the observation group was higher than that of the control group(93.33% vs. 80.00%, P<0.05). After treatment, the levels of C3, C4, blood oxygen saturation and partial pressure of oxygen in both groups were higher than those before treatment(P<0.05), and those in the observation group were higher than those of the control group(P<0.05). The levels of partial pressure of carbon dioxide in both groups were lower than those before treatment(P<0.05), and the observation group was lower than that of the control group(P<0.05). After treatment, the levels of forced expiratory volume in one second, forced vital capacity and their ratio in both groups were higher than those before treatment(P<0.05), and those in the observation group were higher than those of the control group(P<0.05). The TCM symptom score of the observation group was lower than that of the control group(P<0.05). There was no statistically significant difference in adverse reactions between the two groups(P>0.05).
Phlegm-resolving, lung-regulating and asthma-relieving decoction as an adjuvant therapy for the AECOPD with phlegm-heat accumulation in the lung syndrome can improve the therapeutic effect and the levels of C3, C4 and blood gas indicators in patients, without increasing the risk of adverse reactions.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |